Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir
批准号:
10402053
负责人:
NICOLAS PAUL SLUIS-CREMER
金额:
$77.87万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-02 至 2026-07-31
关键词:
AddressAllelesAntigen-Presenting CellsB-Cell ActivationB-LymphocytesBLT miceBloodC-Type LectinsCCR5 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell physiologyCellsCholesterol HomeostasisDNADataDendritic CellsGeneticGoalsHIVHIV-1Helper-Inducer T-LymphocyteIn VitroIndividualInfectionKnowledgeLymphoid TissueMHC Class I GenesMediatingPathogenesisPhenotypePlayProliferatingReportingResistanceRestRoleT-Lymphocyte SubsetsViral PathogenesisViral reservoirViremiaVirus LatencyWithdrawalantiretroviral therapycell typeexperimental studyhumanized mousein vivoinsightlatent HIV reservoirmacrophagenovelparticleperipheral bloodsecondary lymphoid organsingle cell analysistraittransmission processviral reboundviral transmission
中文摘要
总结
HIV-1可以通过释放无细胞颗粒(顺式感染)和通过细胞与细胞之间的相互作用来增殖。
传播(transinfection)。先前的研究表明,HIV-1的跨感染:(i)明显高于
比顺式感染更有效;(ii)可以有效地感染静息的CD 4 + T细胞,这些细胞固有地对顺式感染具有抗性。
感染;和(iii)很大程度上对抗逆转录病毒疗法(ART)的抑制不敏感。因此,HIV-1反式-
感染被认为在HIV-1感染的发病机制中起关键作用。HIV-1反式病毒的直接证据
然而,缺乏体内感染!我们的小组是第一个证明活化的B细胞表达
C型凝集素DC-SIGN具有隔离HIV-1并将其有效转移给旁观者的能力
CD 4 +T细胞。B细胞比其他抗原呈递细胞具有更大的将HIV-1转移到CD 4 + T细胞的能力
细胞,包括树突状细胞(DC)和巨噬细胞。我们最近发现,B细胞,但不是不成熟或
成熟的DC也具有有效地反式感染CD 4+幼稚(TN)细胞的独特能力,所述TN细胞不表达
CCR 5受体-与R5嗜性HIV-1。重要的是,我们已经报道了来自HIV感染者的B细胞
非进展者(NP,在没有ART的情况下控制病毒血症的个体)不支持HIV-1转基因,
感染CD 4 + T细胞。与这些发现一致,从NPs中分离的纯化的CD 4 + TN细胞具有
与ART治疗的进展者相比,HIV-1总DNA的储存量非常小(甚至可以忽略不计)。在此R 01
应用中,我们的首要假设是,B淋巴细胞介导的细胞间HIV-1转感染
有助于在静息的CD 4 + T细胞中建立和补充潜伏病毒库,
特别是CD 4 + TN和T滤泡辅助细胞。我们建议使用新的最先进的方法,
研究这一假设,并期望提供第一个证据表明,HIV-1的反式感染发挥了关键作用,
在病毒发病机制中。
英文摘要
SUMMARY
HIV-1 can proliferate through both the release of cell-free particles (cis-infection) and by cell-to-cell
transmission (trans-infection). Prior studies have shown that HIV-1 trans-infection: (i) is significantly more
efficient than cis-infection; (ii) can efficiently infect resting CD4+ T cells, which are inherently resistant to cis-
infection; and (iii) is largely insensitive to inhibition by antiretroviral therapy (ART). Consequently, HIV-1 trans-
infection is thought to play a key role in the pathogenesis of HIV-1 infection. Direct evidence of HIV-1 trans-
infection in vivo, however, is lacking! Our group was the first to demonstrate that activated B cells express the
C-type lectin DC-SIGN and have the ability to sequester and then efficiently transfer HIV-1 to bystander
CD4+T cells. B cells have a greater capacity to transfer HIV-1 to CD4+ T cells than other antigen presenting
cells, including dendritic cells (DCs) and macrophages. We recently found that B cells, but not immature or
mature DC, also have the unique ability to efficiently trans-infect CD4+ naïve (TN) cells – which do not express
the CCR5 receptor – with R5-tropic HIV-1. Importantly, we have reported that B cells from HIV-infected
nonprogressors (NPs, individuals who control viremia in the absence of ART) do not support HIV-1 trans-
infection of CD4+ T cells. Consistent with these findings, purified CD4+ TN cells isolated from NPs harbor a
very small (or even negligible) reservoir of total HIV-1 DNA, compared to ART-treated progressors. In this R01
application, our overarching hypothesis is that B lymphocyte-mediated cell-to-cell HIV-1 trans-infection
contributes to the establishment and replenishment of the latent viral reservoir in resting CD4+ T cells, in
particular CD4+ TN and T follicular helper cells. We propose to use novel state-of the-art approaches to
investigate this hypothesis, and expect to provide the first evidence that HIV-1 trans-infection plays a key role
in viral pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir
-
批准号:10675438
-
项目类别:
-
资助金额:$72.85万
-
财政年份:2022
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Potent inhibition of HIV-1 latency reversal by PF 03758309
-
批准号:10409846
-
项目类别:
-
资助金额:$18.89万
-
财政年份:2021
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Potent inhibition of HIV-1 latency reversal by PF 03758309
-
批准号:10326435
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2021
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
The "Kick" Revisited in the "Kick and Kill" Strategy
-
批准号:9301475
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2016
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
The "Kick" Revisited in the "Kick and Kill" Strategy
-
批准号:9016996
-
项目类别:
-
资助金额:$22.34万
-
财政年份:2016
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:8143220
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2010
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:9265402
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2009
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:7872929
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2009
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:8079113
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2009
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:8289671
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2009
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
Novel mechanisms of HIV resistance to RTIs
-
批准号:7755208
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2009
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
PROJECT 6
-
批准号:7507632
-
项目类别:
-
资助金额:$10.15万
-
财政年份:2007
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
HIV-1 RT dimerization as an antiviral target
-
批准号:6799016
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2004
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
HIV-1 RT dimerization as an antiviral target
-
批准号:6856525
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2004
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 RT
-
批准号:7097408
-
项目类别:
-
资助金额:$23.32万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 RT
-
批准号:6696403
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 RT
-
批准号:6928996
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 Reverse Transcriptase
-
批准号:7267761
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 RT - Equipment Supplement
-
批准号:9022775
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
NNRTI induced conformational changes in HIV-1 RT
-
批准号:7682790
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2003
-
负责人:NICOLAS PAUL SLUIS-CREMER
-
依托单位:
海外基金